Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
28 887 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32022R0692

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (EU) 2022/692

xx xxx 16.&xxxx;xxxxx 2022,

xxxxxx xx pro účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx

(Xxxx x&xxxx;xxxxxxxx pro EHP)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx na Xxxxxxx x&xxxx;xxxxxxxxx Evropské xxxx,

x&xxxx;xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1272/2008 ze dne 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx xxxxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) x.&xxxx;1907/2006&xxxx;(1), x&xxxx;xxxxxxx xx čl. 37 xxxx.&xxxx;5 xxxxxxxxx xxxxxxxx,

xxxxxxxx x&xxxx;xxxxx důvodům:

(1)

Tabulka 3 x&xxxx;xxxxx 3 přílohy XX nařízení (XX) x.&xxxx;1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxxxxx xxxxx na xxxxxxx xxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 2 až 5 xxxxxxx X&xxxx;xxxxxxxxx xxxxxxxx.

(2)

Xxxxxxxx agentuře xxx xxxxxxxx xxxxx (xxxx xxx „agentura“) xxxx x&xxxx;xxxxxxx s článkem 37 xxxxxxxx (XX) č. 1272/2008 xxxxxxxxxx xxxxxx na xxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxx x&xxxx;xx xxxxxxxxxxx xxxx xxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx jiných xxxxx. Xxxx, xx Xxxxx xxx xxxxxxxxxx rizik (XXX) xxxxxxxx zohlednil xxxxxxxxxx xxxxxxxxxxxx stran, xxxxxx k těmto návrhům xxxxxxxxxxx xxxxxxxxxx&xxxx;(2):

—

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxx, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx syntetický xxxxxxx xxxx křemičitý x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx úpravou,

—

stanovisko xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxx (XXX), [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx β-xxxxxxxxxx (XXX); xxxxxxx xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 4. května 2020 pro xxxxxxxxxxx (ISO); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx tellur,

—

stanovisko xx xxx 11. června 2020 xxx xxxx xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 11. června 2020 xxx tribromderivát 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx piperonylbutoxid (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxx,

—

xxxxxxxxxx ze dne 11.&xxxx;xxxxxx&xxxx;2020 pro xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx kyselinu,

—

stanovisko ze xxx 11. června 2020 pro xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx fluopikolid (ISO); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—

xxxxxxxxxx ze dne 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-ethylhexanovou xxxxxxxx x&xxxx;xxxx xxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 ohledně xxxxxxxxxx posouzení xxxxxxxx xxxxxxxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx kyseliny x&xxxx;xxxxxx xxxxxxxxxxxx a pentadraselných xxxx xx xxxxxx Xxxxxxxx xxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx xxx 17. září 2020 xxx xxxxxxxxx xxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxxx (ISO); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 pro 4,4’-oxydi(benzensulfonohydrazid),

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx toluen-4-sulfonohydrazid,

—

stanovisko xx xxx 17. září 2020 pro xxxxxxxxx; 1,3-dimethyl-3,7-dihydro-1H-purin-2,6-dion,

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX],

—

xxxxxxxxxx xx xxx 17. září 2020 xxx 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI],

—

stanovisko xx xxx 17. září 2020 xxx 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx triamid xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxx,

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 pro 2-ethyl-2-{[(1-oxoallyl)oxy]methyl}propan-1,3-diyl-diakrylát; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; xxxxxxxxxxxxxxxxx-xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 17. září 2020 xxx 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující &xx;&xxxx;0,1&xxxx;% xxxx. částic x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším než 50 μm],

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující ≥ 0,1 % xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μx],

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxx amonný,

—

stanovisko ze xxx 8. října 2020 xxx 2,4,6-xxx-xxxx-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxxxx (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxx-2-xxxxx-1-xxxx, sodnou xxx; xxxxxx xxx xxxxxxxxxx; xxxxxxxxx sodný,

—

stanovisko ze xxx 8. října 2020 xxx X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 2-(2-xxxxxxxxxxxxx)xxxxxxx; diethylenglykolmonomethylether,

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro 4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxxxxxxxx (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxx 4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Xxxx 124,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx kyselinu xxxxxxxxxxxxxxxxxx; xxxxxxxx xxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[alkyl-(C12-C18, rozvětvené, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X10-X13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 1,3,5-triazin-2,4,6-triamin; melamin,

—

stanovisko xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥ 78 % xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% anti-isomerů], isopyrazam,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx margosy, xxxxxxxx [x&xxxx;xxxxx rostliny Xxxxxxxxxxx xxxxxx, xxxxxxxxxxx vodou x&xxxx;xxxx xxxxxxxxxx organickými xxxxxxxxxxxx],

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx xxxxxxxxx,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 pro xxxxxxxx (XXX), 3-isopropyl-2,1,3-benzothiadiazin-4-on-2,2-dioxid,

—

stanovisko xx xxx 10. prosince 2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxx o akutní xxxxxxxxx xxxxxxxx 2-butoxyethan-1-olu; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) na žádost Xxxxxxxx komise.

(3)

Byly xxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxx xx xxxxxxxxxxxx XXX xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx; xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx opětovného xxxxxxxxx xxxxxxxx xxxxxxxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx a jejích pentasodných x&xxxx;xxxxxxxxxxxxxxx xxxx na xxxxxx Xxxxxxxx xxxxxx, xx xxx 8. října 2020 xxx xxxxxx xxxxxx, xx dne 10. prosince 2020 xxx oxid xxxxxxxxx, xx dne 10. prosince 2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxx informací o akutní xxxxxxxxx xxxxxxxx 2-butoxyethan-1-olu; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Evropské komise x&xxxx;xx xxx 10. prosince 2020 xxx xxxxxxx.

(4)

Xxxxxx xxxx xxxxxxxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx xx xx xxxxxxxxxx x&xxxx;xxxx, aby xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx xx stanoviscích XXX. Na xxxxxxx xxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx xx xxxxx xxxxxx xxxxxx, xxxxxxxxxxxx xxxx zrušit xxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxx.

(5)

Xxxx, co bylo Xxxxxx xxxxxxx stanovisko XXX, xxxx xxxxxxxx xxxxxxxxx informace xxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx hydrolýzy x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx s povrchovou úpravou. Xxxxxxxxxxx silanaminu, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx syntetického xxxxxxxxx xxxxx křemičitého x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx 2, xxxxxxxxxx ve xxxxxxxxxx XXX xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019, by xxxxxx xxx zařazena do xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008, neboť Xxxxxx xxxx vědecké xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxx, xx xx xxxx xxxxx xxxxx xxxxxxxxx XXX. Do xxxxxxx XX xxxxxxxx (ES) x.&xxxx;1272/2008 xx xxxx xxxx xxx xxxxxxxx xxxxxxxxxxx xxxx xxxxx xxxx XXXX XX 2, doporučená ve xxxxxxxxxx xxxxxx XXX xx xxx 5. prosince 2019, xxxxx nebyly xxxxxxxx xxxxx xxxx xxxxxxxxx, xxxxx xx xxxxxxxxxx xxxxx xxxxxxxxx xxxx xxxxxxxxxxx.

(6)

Xxxxxxxx (XX) x.&xxxx;1272/2008 xx proto mělo xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx nebo xxxxxxxxxxxxxxx harmonizovaných klasifikací xx xxxxxx xxx xxxxxxxxxx xxxxx, xxxxxxx xxxxxxxxxx potřebují určitou xxxx xx xx, xxx xxxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx xxxxx xxxx aktualizovaným xxxxxxxxxxxx a prodali xxxxxxxxx xxxxxx, na xxxxx xx vztahují xxxxxxxxx xxxxxxxxxxx požadavky. Xxxx xxxx je rovněž xxxxxxxx x&xxxx;xxxx, xxx xxxxxxxxxx xxxx xxxxxxxx xxxx přijmout xxxxxxxx xxxxx k zajištění trvalého xxxxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxx, které vznikají x&xxxx;xxxxxxxx xxxx provedených xxxxx xxxxxx xxxxxxxx. Xxxxxxxxxxx xx xxxx xxxx být xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx způsobem přizpůsobit xxxxxxxxxx a balení xx xxxxxxxxxxx základě před xxxxx xxxxxxxxxxxxx tohoto xxxxxxxx, xxx xxxx xxxxxxxxx vysoká xxxxxx xxxxxxx xxxxxxxx zdraví x&xxxx;xxxxxxxxx xxxxxxxxx a aby xx xxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Článek 1

Změny xxxxxxxx (ES) x.&xxxx;1272/2008

Xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxx xxxxxx nařízení.

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx a použitelnost

Toto xxxxxxxx vstupuje v platnost xxxxxxxx dnem xx xxxxxxxxx x&xxxx;Xxxxxxx věstníku Xxxxxxxx xxxx.

Xxxxxxx xx xxx xxx 23. listopadu 2023.

Xxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx xxxxxx xxxxx být látky x&xxxx;xxxxx xxxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxx xxxxxxxxx xxx xxx xxxx xxxxxx x&xxxx;xxxxxxxx.

Xxxx xxxxxxxx xx xxxxxxx x&xxxx;xxxxx rozsahu x&xxxx;xxxxx xxxxxxxxxx ve xxxxx xxxxxxxxx xxxxxxx.

X&xxxx;Xxxxxxx xxx 16.&xxxx;xxxxx 2022.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx VON XXX XXXXX

(1)&xxxx;&xxxx;Xx. xxxx. X&xxxx;353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;Xxxxxxxxxx xxxx xxxxxxxx xx xxxx xxxxxxxxxxx stránce: https://echa.europa.eu/registry-of-clh-intentions-until-outcome/-/dislist/name/-/ecNumber/-/casNumber/-/dte_receiptFrom/-/dte_receiptTo/-/prc_public_status/Opinion+Adopted/dte_withdrawnFrom/-/dte_withdrawnTo/-/sbm_expected_submissionFrom/-/sbm_expected_submissionTo/-/dte_finalise_deadlineFrom/-/dte_finalise_deadlineTo/-/haz_addional_hazard/-/lec_submitter/-/dte_assessmentFrom/-/dte_assessmentTo/-/prc_regulatory_programme/-/. – Xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 x&xxxx;xx xxx 10. prosince 2020 xxxxxxxx xx xxxxxxxxxx xxxxxxxxx xx xxxxxx Xxxxxxxx xxxxxx xxxx x&xxxx;xxxxxxxxx xx xxxx internetové xxxxxxx: https://echa.europa.eu/about-us/who-we-are/committee-for-risk-assessment/opinions-of-the-rac-adopted-under-specific-echa-s-executive-director-requests

XXXXXXX

Xxxxxxx XX xxxxxxxx (XX) č. 1272/2008 xx xxxx takto:

1)

v části 3 xx xxxxxxx 3 xxxx takto:

a)

vkládají xx xxxx položky:

Indexové číslo

Chemický xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX

Xxxxxxxx

Xxxx tříd x&xxxx;xxxxxxxxx nebezpečnosti

Kódy xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx xxx o nebezpečnosti

Kódy xxxxx. standardních xxx x&xxxx;xxxxxxxxxxxxx

„014-052-00-7

xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx s oxidem křemičitým; xxxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx úpravou

272-697-1

68909-20-6

STOT XX 2

X373 (plíce) (xxxxxxxxxx)

XXX08

Xxx

X373 (xxxxx) (xxxxxxxxxx)

XXX066“

„035-005-00-7

xxxxxx xxxxxx

235-183-8

12124-97-9

Xxxx. 1X

Xxxx.

XXXX XX 3

XXXX XX 1

Xxx Xxxxx. 2

X360XX

X362

X336

X372 (xxxxxxx systém)

H319

GHS08

GHS07

Dgr

H360FD

H362

H336

H372 (xxxxxxx xxxxxx)

X319“

„050-032-00-4

xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx)

220-481-2

2781-10-4

Xxxx. 2

Xxxx. 1X

XXXX XX 1

X341

X360XX

X372 (xxxxxxxx xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„050-033-00-X

xxxxxxxxxx-xxxxxxxx

213-928-8

1067-33-0

Xxxx. 2

Xxxx. 1B

STOT XX 1

X341

X360XX

X372 (imunitní xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„052-001-00-0

xxxxxx

236-813-4

13494-80-9

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„052-002-00-6

xxxx xxxxxxxxxxx

231-193-1

7446-07-3

Xxxx. 1B

Lact.

H360Df

H362

GHS08

Dgr

H360Df

H362“

„056-005-00-3

tetraoxid xxxxxxx-xxxxxxxx

237-222-4

13701-59-2

Xxxx. 1X

Xxxxx Xxx. 4

Xxxxx Tox. 3

X360XX

X332

X301

XXX08

XXX06

Xxx

X360XX

X332

X301

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 100&xxxx;xx/xx XX“

„601-097-00-8

xxxxxxxxxxxx

203-132-9

103-65-1

Xxxx. Xxx. 3

Xxx. Xxx. 1

XXXX SE 3

Xxxxxxx Xxxxxxx 2

H226

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H304

H335

H411“

„603-243-00-6

tribromderivát 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx

253-057-0

36483-57-5; 1522-92-5

Xxxx. 1X

Xxxx. 2

X350

X341

XXX08

Xxx

X350

X341“

„604-096-00-0

xxxxxxxxxxxxxxxx (ISO); 5-{[2-(2-butoxyethoxy)ethoxy]methyl}-6-propyl-1,3-benzodioxol

200-076-7

51-03-6

STOT XX 3

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X335

X319

X400

X410

XXX07

XXX09

Xxx

X335

X319

X410

XXX066

X&xxxx;= 1

M = 1“

„604-097-00-6

2,4,6-xxx-xxxx-xxxxxxxxxx

211-989-5

732-26-3

Xxxx. 1B

Acute Tox. 4

XXXX XX 2

Xxxx Xxxx. 1X

X360X

X302

X373 (xxxxx)

X317

XXX08

XXX07

Xxx

X360X

X302

X373 (xxxxx)

X317

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX“

„604-098-00-1

4,4’-xxxxxxxxxxxxxxx; xxxxxxxx S

201-250-5

80-09-1

Repr. 1X

X360XX

XXX08

Xxx

X360XX“

„606-153-00-5

xxxxxxxxxx

204-337-6

119-61-9

Xxxx. 1X

X350

XXX08

Xxx

X350“

„606-154-00-0

xxxxxxxxxxx (XXX); 2-amino-3-chlor-1,4-naftochinon

220-529-2

2797-51-5

Carc. 2

Xxxx. 2

Xxxxx Tox. 4

XXXX XX 2

Eye Xxxxx. 2

Xxxx Sens. 1&xxxx;X

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H302

H373 (xxxxxx xxxx, ledviny)

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H302

H373 (xxxxxx xxxx, ledviny)

H319

H317

H410

orální:

ATE = 500 mg/kg XX

X&xxxx;= 10

X&xxxx;= 10“

„607-756-00-6

xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx

227-561-6

5888-33-5

Xxxx Xxxx. 1&xxxx;X

X317

XXX07

Xxx

X317“

„607-757-00-1

xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxx kyselina

216-485-9

1596-84-5

Carc. 2

X351

XXX08

Xxx

X351“

„607-758-00-7

4,4′-xxxxx(xxxxxxxxxxxxxxxxxxxxx)

201-286-1

80-51-3

Xxxx-xxxxx. X

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X242

X400

X410

XXX02

XXX09

Xxx

X242

X410

X&xxxx;= 1

X&xxxx;= 1“

„607-759-00-2

xxxxxx-4-xxxxxxxxxxxxxxx

216-407-3

1576-35-8

Xxxx-xxxxx. D

H242

GHS02

Dgr

H242“

„607-760-00-8

2-{N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino}ethyl-acetát; C.I. Xxxxxxxx Xxxx 124

239-203-6

15141-18-1

Skin Xxxx. 1&xxxx;X

X317

XXX07

Xxx

X317

Xxxx Xxxx. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„607-761-00-3

xxxxxxxxxxxxxxxxx xxxxxxxx; tridekafluorheptanová xxxxxxxx

206-798-9

375-85-9

Xxxx. 1X

XXXX XX 1

H360D

H372 (xxxxx)

XXX08

Xxx

X360X

X372 (xxxxx)“

„607-762-00-9

xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; xxxxxxxxxxx

-

283159-90-0

Xxxx. 2

Xxxxxxx Chronic 2

H351

H411

GHS08

GHS09

Wng

H351

H411“

„607-763-00-4

6-[alkyl-(C12-C18, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanová kyselina, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx

-

-

Xxxx. 1X

Xxx Xxxxx. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319“

„607-764-00-X

6-[alkyl-(C10-C13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx

-

2156592-54-8

Xxxx. 1X

Xxx Xxxxx. 2

H360FD

H319

GHS08

GHS07

Dgr

H360FD

H319“

„607-765-00-5

6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx

-

-

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX“

„613-341-00-0

xxxxxxxxxxx (ISO); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx

277-728-2

74115-24-5

Xxxxxxx Xxxxxxx 1

X410

XXX09

Xxx

X410

X&xxxx;= 1“

„613-342-00-6

xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx

200-385-7

58-55-9

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„613-343-00-1

xxxxxxxxx (ISO); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx

-

179101-81-6

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 100“

„613-344-00-7

xxxxxxx-2-xxxxx-1-xxxx, xxxxx sůl; sodná xxx xxxxxxxxxx; xxxxxxxxx xxxxx

223-296-5;

240-062-8

3811-73-2;

15922-78-8

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Acute Xxx. 4

XXXX XX 1

Xxxx Xxxxx. 2

Eye Xxxxx. 2

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 2

X331

X311

X302

X372 (xxxxxxx xxxxxx)

X315

X319

X317

X400

X411

XXX06

XXX08

XXX09

Xxx

X331

X311

X302

X372 (xxxxxxx xxxxxx)

X315

X319

X317

X410

XXX070

xxxxxxxxx:

XXX&xxxx;= 0,5 mg/l (xxxxx nebo mlha)

dermální:

ATE = 790&xxxx;xx/xx TH

orální:

ATE = 500 mg/kg XX

X&xxxx;= 100“

„613-345-00-2

1,3,5-triazin-2,4,6-triamin;

melamin

203-615-4

108-78-1

Carc. 2

XXXX XX 2

H351

H373 (močové xxxxx)

XXX08

Xxx

X351

X373 (močové xxxxx)“

„615-046-00-2

1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX]

220-474-4

2778-42-9

Xxxx. Xxxx. 1

Xxxx Xxxx. 1 A

H334

H317

GHS08

Dgr

H334

H317“

„615-047-00-8

1,3-bis(isokyanatomethyl)benzen; [x-XXX]

222-852-4

3634-83-1

Xxxx. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317

Xxxx Xxxx. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„615-048-00-3

2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx

218-485-4

2162-73-4

Xxxx. Sens. 1

Xxxx Sens. 1

X334

X317

XXX08

Xxx

X334

X317“

„615-049-00-9

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% hmot. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μx]

221-641-4

3173-72-6

XXXX XX 3

Xxxx Irrit. 2

Xxx Irrit. 2

Xxxx. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

Xxxxxxx Xxxxxxx 3

X335

X315

X319

X334

X317

X412

XXX07

XXX08

Xxx

X335

X315

X319

X334

X317

X412“

„615-050-00-4

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx průměrem xxxxxx xxx 50 μx]

221-641-4

3173-72-6

Xxxxx Xxx. 2

XXXX SE 3

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Xxxx. Xxxx. 1

Xxxx Sens. 1&xxxx;X

Xxxxxxx Xxxxxxx 3

X330

X335

X315

X319

X334

X317

X412

XXX06

XXX08

Xxx

X330

X335

X315

X319

X334

X317

X412

xxxxxxxxx:

XXX&xxxx;= 0,27&xxxx;xx/x (xxxxx nebo xxxx)“

„616-237-00-3

xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx

-

239110-15-7

Xxxx. 2

H361d

GHS08

Wng

H361d“

„616-238-00-9

triamid xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx

477-690-9

874819-71-3

Xxxx. 1B

STOT XX 2

H360Fd

H373 (ledviny)

GHS08

Dgr

H360Fd

H373 (xxxxxxx)“

„616-239-00-4

X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx

-

1255734-28-1

Xxxx. 2

Acute Xxx. 4

Skin Xxxx. 1X

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X361x

X332

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X361x

X332

X317

X410

xxxxxxxxx:

XXX&xxxx;= 2,2&xxxx;xx/x (xxxxx xxxx mlha)

M = 10

X&xxxx;= 1“

„616-240-00-X

reakční xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx

-

881685-58-1

Xxxx. 2

Xxxx. 1B

Skin Sens. 1X

Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1

X351

X360X

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X360X

X317

X410

Xxxx. 1X; X360X:

X&xxxx;≥&xxxx;3&xxxx;%

X&xxxx;= 10

X&xxxx;= 10“

„650-058-00-1

Xxxxxxx, xxxxxxx [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx indica, xxxxxxxxxxx vodou a dále xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx]

283-644-7

84696-25-3

Xxxx. 2

Xxxx Sens. 1

Xxxxxxx Xxxxxxx 1

X361x

X317

X410

XXX08

XXX07

XXX09

Xxx

X361x

X317

X410

X&xxxx;= 10“

b)

položky xxxxxxxxxxxx xxxxxxxxx xxxxxx 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 xx xxxxxxxxx xxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx ES

Číslo XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx faktory x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx a kategorií xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx a signálních xxxx

Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„014-001-00-9

xxxxxxxxxxxxx

233-042-5

10025-78-2

Xxxx. Xxx. 1

Xxxxx-xxxxx. 1

Acute Tox. 3

Xxxxx Xxx. 4

Xxxx Xxxx. 1&xxxx;X

Xxx Dam. 1

X224

X260

X331

X302

X314

X318

XXX02

XXX06

XXX05

Xxx

X224

X260

X331

X302

X314

XXX014

XXX029

XXX071

xxxxxxxxx:

XXX&xxxx;= 7,6&xxxx;xx/x (páry)

orální:

ATE = 1&xxxx;000  mg/kg XX“

„023-001-00-8

xxxx xxxxxxxxx

215-239-8

1314-62-1

Xxxx. 2

Carc. 1X

Xxxx. 2

Xxxx.

Xxxxx Xxx. 3

Xxxxx Xxx. 2

XXXX XX 3

XXXX XX 1

Aquatic Xxxxxxx 2

H341

H350

H361fd

H362

H301

H330

H335

H372 (xxxxxxx xxxxx, vdechování)

H411

GHS06

GHS08

GHS09

Dgr

H341

H350

H361fd

H362

H301

H330

H335

H372 (xxxxxxx xxxxx, xxxxxxxxxx)

X411

xxxxxxxxx:

XXX&xxxx;= 0,05&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 220&xxxx;xx/xx XX“

„601-024-00-X

xxxxx

202-704-5

98-82-8

Xxxx. Liq. 3

Xxxx. 1X

Xxx. Xxx. 1

XXXX XX 3

Xxxxxxx Xxxxxxx 2

H226

H350

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H350

H304

H335

H411“

„603-014-00-0

2-butoxyethan-1-ol; xxxxxxxxxxxxx-xxxxxxxxx-xxxxx

203-905-0

111-76-2

Xxxxx Xxx. 3

Xxxxx Xxx. 4

Xxxx Xxxxx. 2

Eye Xxxxx. 2

X331

X302

X315

X319

XXX06

Xxx

X331

X302

X315

X319

xxxxxxxxx:

XXX&xxxx;= 3&xxxx;xx/x (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;200 &xxxx;xx/xx XX“

„603-107-00-6

2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

203-906-6

111-77-3

Xxxx. 1X

X360X

XXX08

Xxx

X360X

Xxxx. 1X; X360X: C ≥ 3 %“

„604-030-00-0

4,4′-isopropylidendifenol; xxxxxxxx X

201-245-8

80-05-7

Xxxx. 1X

XXXX XX 3

Xxx Xxx. 1

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X360X

X335

X318

X317

X400

X410

XXX08

XXX07

XXX05

XXX09

Xxx

X360X

X335

X318

X317

X410

X&xxxx;= 1

X&xxxx;= 10“

„607-111-00-9

2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx;

xxxxxxxxxxxxxxxxx-xxxxxxxxxx

239-701-3

15625-89-5

Xxxx. 2

Skin Xxxxx. 2

Xxx Xxxxx. 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X315

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X315

X319

X317

X410

X&xxxx;= 1

X&xxxx;= 1

D“

„607-230-00-6

2-ethylhexanová kyselina x&xxxx;xxxx soli, x&xxxx;xxxxxxxx xxxx, xxxxx jsou xxxxxxx xxxxx x&xxxx;xxxx xxxxxxx

-

-

Xxxx. 1B

H360D

GHS08

Dgr

H360D“

„607-253-00-1

cyfluthrin (XXX); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

269-855-7

68359-37-5

Xxxx.

Xxxxx Xxx. 2

Xxxxx Xxx. 2

XXXX XX 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (nervový xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,14&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 14&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1&xxxx;000&xxxx;000 “

„607-254-00-7

β-xxxxxxxxxx (XXX); xxxxxxx směs: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

-

1820573-27-0

Xxxx.

Xxxxx Tox. 2

Xxxxx Tox. 2

XXXX XX 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X362

X330

X300

X370 (xxxxxxx systém)

H400

H410

GHS06

GHS08

GHS09

Dgr

H362

H330

H300

H370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,081 mg/l (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 11&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1 000 000 “

„607-734-00-6

xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(ethan-1,2-diylnitrilo)pentaacetát

404-290-3

7216-95-7

Repr. 1B

Acute Xxx. 4

XXXX XX 2

Xxx Xxxxx. 2

X360X

X332

X373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-735-00-1

{[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx

200-652-8

67-43-6

Xxxx. 1X

Xxxxx Xxx. 4

XXXX XX 2

Xxx Xxxxx. 2

X360X

X332

X373 (vdechování)

H319

GHS08

GHS07

Dgr

H360D

H332

H373 (xxxxxxxxxx)

X319

Xxxx. 1X; H360D: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-736-00-7

xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]

205-391-3

140-01-2

Xxxx. 1B

Acute Xxx. 4

XXXX XX 2

X360X

X332

X373 (xxxxxxxxxx)

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx nebo xxxx)“

„608-032-00-2

xxxxxxxxxxx (ISO); (1E)-N-[(6-chlorpyridin-3-yl)methyl]-N’-kyan-N-methylethanimidamid; (X)-X 1-[(6-chlor-3-pyridyl)methyl]-N 2-kyan-N 1-xxxxxxxxxxxxxxxx

-

135410-20-7&xxxx;160430-64-8

Xxxx. 2

Xxxxx Xxx. 3

Xxxxxxx Xxxxxxx 1

Aquatic Xxxxx 1

X361x

X301

X410

X400

XXX08

XXX06

XXX09

Xxx

X361x

X301

X410

xxxxxx:

XXX&xxxx;= 140 mg/kg XX

X&xxxx;= 10

X&xxxx;= 10“

„609-042-00-X

xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx

254-938-2

40487-42-1

Xxxx. 2

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 100

X&xxxx;= 10“

„613-012-00-1

xxxxxxxx (XXX); 3-xxxxxxxxx-1X-2,1,3-xxxxxxxxxxxxxxx-4(3X)-xx-2,2-xxxxxx

246-585-8

25057-89-0

Xxxx. 2

Xxxxx Xxx. 4

Xxx Xxxxx. 2

Xxxx Sens. 1

H361d

H302

H319

H317

GHS08

GHS07

Wng

H361d

H302

H319

H317

orální: XXX&xxxx;= 1 600 &xxxx;xx/xx XX“

„616-164-00-7

xxxxxxxxxxxxx (ISO); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

Xxxx. 2

Repr. 2

Xxxxx Xxx. 4

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H332

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H332

H410

inhalační:

ATE = 1,3&xxxx;xx/x (xxxxx xxxx xxxx)

X&xxxx;= 100

X&xxxx;= 100“

c)

položka xxxxxxxxxxxx indexovému xxxxx 615-007-00-X se xxxxxxx.